Innoviva (INVA) Other Non Operating Income (2011 - 2026)
Innoviva (INVA) posted Other Non Operating Income of -$366000.0 for Q1 2026, up 83.75% on a QoQ basis from -$2.3 million in Q3 2025, and up 63.25% year-over-year from -$224191.9 in Q1 2025.
Innoviva (INVA) Other Non Operating Income (2011 - 2026) Analysis & Trends
Innoviva's Other Non Operating Income history runs 16 years deep, the most recent figure standing at -$366000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 63.25% year-over-year to -$366000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.4 million (up 30.61% YoY) and the FY2025 annual result came in at $324000.0, up 260.0% from the prior year.
- Other Non Operating Income was -$366000.0 for Q1 2026 at Innoviva, up from -$2.3 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $266.7 million in Q3 2022 and bottomed at -$4.3 million in Q3 2023.
- A 5-year average of $20.8 million and a median of -$1.1 million in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income tumbled 438.4% — and 2026, when it jumped 63.25%.
- Innoviva's Other Non Operating Income stood at $266.7 million in 2022, then plunged by 101.61% to -$4.3 million in 2023, then climbed by 27.19% to -$3.1 million in 2024, then advanced by 27.89% to -$2.3 million in 2025, then soared by 83.75% to -$366000.0 in 2026.
- Business Quant data shows INVA's Other Non Operating Income at -$366000.0 in Q1 2026, -$2.3 million in Q3 2025, and -$777000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -366,000.00 |
| Sep 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | -777,000.00 |
| Mar 31, 2025 | -996,000.00 |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -973,000.00 |
| Mar 31, 2024 | -1.24 Mn |
| Sep 30, 2023 | -4.29 Mn |
| Jun 30, 2023 | -1.90 Mn |
| Mar 31, 2023 | -1.35 Mn |
| Sep 30, 2022 | 266.70 Mn |
| Mar 31, 2022 | -250,000.00 |
| Mar 31, 2021 | -433,000.00 |
| Dec 31, 2020 | -85,000.00 |
| Sep 30, 2020 | -13,000.00 |
| Jun 30, 2020 | 30,000.00 |
| Mar 31, 2020 | 68,000.00 |
| Dec 31, 2019 | -223,000.00 |
| Sep 30, 2019 | -115,000.00 |
| Jun 30, 2019 | -8,000.00 |